Sector Alpha Week of 2026-09-17
Not SEBI Registered !! Not Investment advice !!
Sector Alpha — machine-written from the numbers · Data as of 2026-09-17

Dynatrace, Inc.

DT
Technology · Software - Application

Dynatrace, Inc.'s price has outrun its earnings. +14.1% in a year against EPS −66.0% — the market is paying now for delivery later.

The sharpest disagreement: the price moved +14.1% in a year while annual EPS moved −66.0% — the difference is re-rating, and re-rating has to be repaid with earnings.

The price is topping out (13 weeks in) while the P/E sits at the 72nd percentile of its own 5-year range. Underneath, the last four quarters read deteriorating — profit −50.0% year on year, and 177% of the last 3 years' profit arrived as cash. What settles it: whether earnings grow into a price that has already moved.

Stage
Deteriorating
fundamental trajectory, 12 quarters
Price
$55.2
+14.1% 1Y
P/E
110.4×
72nd pctile
of its own 5-year range
Revenue (Mar 26)
$0.5 B
+17.8% YoY
Profit (Mar 26)
$0.0 B
−50.0% YoY
Operating margin
7.5%
−1.4 pp YoY
ROE
6%
FY26
ROIC
8.9%
vs WACC 8.2% → +0.7 pp
Cash conversion
177%
of profit, last 3 FY
01 · Price story

Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.

Dynatrace, Inc. trades at $55.2, losing momentum at the top and 13 weeks into that stage. That is +32.0% against its own 200-day average. It sits at 100% of a 52-week range of $32 to $55. On relative strength it has been ahead of the S&P 500 on a trailing-13-week view for 13 straight weeks.

Today the stock is losing momentum at the top — week 13 of stage 3. At $55.2 it trades +32.0% versus its 200-day average and sits at 100% of its 52-week range ($32–$55).

Sep 26: $55.2 Weekly closing price ($) with 50- and 200-day averages; shaded bands mark the price stage (grey base, green advance, amber top, red decline). 3-year window.
+32.0% versus the 200-day line, week 13 of stage 3
Price50-day avg200-day avg
S2S1S3S1S4S3$63.6$55.2$46.8$38.4$30.0$$55$42Sep 23Jun 24Mar 25Dec 25Sep 26
S2S1S3S1S4S3$63.6$55.2$46.8$38.4$30.0$$55$42Sep 23Mar 25Sep 26
Beating or trailing, week by week since 2019 Each cell is one week from 2019 to now (373 weeks): the stock's trailing 13-week return minus the S&P 500's, green ahead / red behind (±25% ramp). Grey cells are the 13-week warm-up or weeks where the S&P 500 reading is not held.
trailing 13-week return vs the S&P 500
Aug 19Sep 26

Against the market, two honest reads. Cumulative: over the last 7.1 years the stock moved +112% while the S&P 500 moved +158% — behind the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 13 straight weeks — the ribbon below is that same metric, week by week.

What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.

02 · Valuation

Valuation P/E is the price of $1 of annual profit: how many dollars the market pays for each dollar the company earns in a year.

Dynatrace, Inc. trades at 110.4× P/E, at the pricey end of its own range (72nd percentile). Its long-run median P/E is 90.0×, measured across 4.5 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.

Today's P/E of 110.4× is at the pricey end of its own range (72nd percentile), against a long-run median of 90.0× measured over 4.5 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.

P/E 110.4× vs a 90.0× long-run median P/E, weekly (left axis); earnings per share, trailing twelve months, weekly step line (right axis). 4.5-year window; loss-period spikes above 270× shown pinned at the top. The eps (ttm) bars are red where the reading is lower than the quarter before.
at the pricey end of its own range (72nd percentile)
P/EMedianEPS (TTM) (quarterly)
289.6×$1.8218.9×$1.4148.1×$0.977.3×$0.56.6×$0.0×$102.20×$1Apr 22May 23Jun 24Aug 25Sep 26
289.6×$1.8218.9×$1.4148.1×$0.977.3×$0.56.6×$0.0×$102.20×$1Apr 22Jun 24Sep 26
PEG 1.18 PEG ratio per quarter — the P/E divided by the earnings-growth rate. The dashed line marks 1.0: below it the growth is cheap against the multiple, above it the price already prices the growth in. Last 19 quarters; values above 6 pinned at the top.
above 1.0, the multiple already banks the growth
PEGPEG = 1.0
6.4×5.0×3.5×2.0×0.6××1.18×Sep 21Sep 22Dec 23Dec 24Mar 26
6.4×5.0×3.5×2.0×0.6××1.18×Sep 21Dec 23Mar 26
P/E
110.4×
72nd percentile of 5y
PEG
1.75
as reported

🚨 Why the multiple sits where it does: over the past year annual EPS moved −66.0% against a +14.1% price move — the price outran earnings, pushing the multiple UP its own range.

The price move, decomposed: over 3y, of the +5.9%/yr price move, ~+3.3%/yr came from earnings growth and ~+2.6 pp from the multiple (expanding). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.

Put together: the multiple is full against its own past, so the story rests on the earnings line underneath it, not the multiple.

03 · Stage: Deteriorating

Stage: Deteriorating Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).

Dynatrace, Inc. reads as deteriorating on its fundamental arc. Deteriorating — profit and EPS growth are shrinking (profit growth −64.6% latest against +800.0% at its 12-quarter best), ROCE holding at 8.6%. The read is built from 12 quarters across 4 curves, on full evidence.

Growth, year by year: revenue +18.8% in FY26, profit −66.7% Year-over-year growth per fiscal year, %: revenue (left axis); net profit and EPS (right axis — profit growth swings far wider). Zero line drawn.
Revenue YoYProfit YoYEPS YoY
25%243%23%160%22%77%20%−6.5%18%−90%%%18.8%−66.7%FY22FY24FY26
25%243%23%160%22%77%20%−6.5%18%−90%%%18.8%−66.7%FY22FY24FY26
Three growth curves, twelve quarters Year-on-year growth of trailing-twelve-month revenue (left axis), profit and EPS (right axis — they swing far wider), % at each quarter-end. Base-effect spikes shown pinned (▲). A missing point means that reading is not held for the quarter.
the trajectory the stage is read from · revenue stabilising, profit rolling over
RevenueProfitEPS
24%329%23%223%21%117%19%11%18%−96%%%18.1%−64.6%−66.3%Jun 23Sep 24Mar 26
24%329%23%223%21%117%19%11%18%−96%%%18.1%−64.6%−66.3%Jun 23Sep 24Mar 26
ROCE Trailing-twelve-month operating profit (before interest and tax) as a share of average capital employed — total assets minus current liabilities, the standard textbook basis, %.
the return curve, computed quarterly
ROCE
8.7%8.2%7.8%7.3%6.8%%8.6%Jun 23Dec 23Sep 24Jun 25Mar 26
8.7%8.2%7.8%7.3%6.8%%8.6%Jun 23Sep 24Mar 26
Revenue growth
Steady high
latest +18.1% · span +18.1% to +24.0%
Profit growth
Falling
latest −64.6% · span −64.6% to +800.0%
EPS growth
Falling
latest −66.3% · span −66.3% to +560.0%
ROCE
Stuck low
latest 8.6% · span 6.9%–8.6%

🚨 Why it matters: falling curves mean every cheap-looking ratio below needs a discount for direction.

Compound annual growth rate (%) Compound annual growth rate over each window, %. Revenue, profit and EPS from fiscal-year figures; stock price is the price CAGR over the same spans. A dash = that window is not held, or the base was a loss.
1yr3yr5yr10yr
Revenue+18.8%+20.3%
Profit−66.7%+13.3%
EPS−66.0%+13.4%
Stock price+14.1%+5.9%−5.1%
Revenue YoY (Mar 26)
+17.8%
latest quarter vs a year ago
Profit YoY (Mar 26)
−50.0%
latest quarter vs a year ago
Revenue 10y
21.4%
long-run compound pace
04 · 4-Factor Sector Score

4-Factor Sector Score

49.1/100 — rank 17 of 30 in Software - Application · 56% evidence confidence

Dynatrace, Inc. scores 49.1 out of 100 against the 30 companies it is compared with in Software - Application, ranking 17. Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.

The four contributions add to the total exactly: 14.7 + 9.6 + 8.9 + 15.9 = 49.1. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.

What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.

05 · Revenue

Revenue Revenue is the top line: everything the company billed its customers in the period.

Dynatrace, Inc. reported $0.5 B of revenue in the Mar 26 quarter, +17.8% year on year. That is the 12th straight quarter of year-on-year growth. Over 4 years it has compounded at 21.4% a year. The last full year, FY26, came in at $2.0 B. The last four reported quarters add to $2.0 B.

FY26 revenue came in at $2.0 B (+18.8% on the year), capping 4 years at 21.4% compound. The latest quarter (Mar 26) printed $0.5 B, +17.8% year on year — the 12th consecutive quarter of year-over-year growth.

FY26 revenue $2.0 B (+18.8% YoY) Revenue bars, $ B (left); YoY growth-% line (right). 5-year window. A bar is red when it is lower than the year before.
21.4% a year over 4 years
RevenueYoY growth
2.225%1.623%1.122%0.520%0.018%$ B%$2B18.8%FY22FY24FY26
2.225%1.623%1.122%0.520%0.018%$ B%$2B18.8%FY22FY24FY26
Mar 26: $0.5 B (+17.8% YoY) Quarterly revenue bars, $ B (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
12th straight quarter of growth
Revenue (quarterly)YoY growth
0.626%0.423%0.321%0.118%0.016%$ B%$1B17.8%Jun 23Sep 24Mar 26
0.626%0.423%0.321%0.118%0.016%$ B%$1B17.8%Jun 23Sep 24Mar 26

Pace check: the last four quarters averaged +18.2% growth against the decade's 21.4% — the current year is running slower than its own long-run rate.

Acceleration check: trailing-twelve-month revenue grew +18.1% over the last 4 quarters against +18.9%/yr over the last 8 — stabilising; TTM profit −64.6% vs +6.5%/yr — rolling over.

06 · Operating margin

Operating margin Operating margin is what is left of every $100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.

Dynatrace, Inc.'s operating margin is 7.5% in the Mar 26 quarter, −1.4 percentage points against the same quarter a year ago. That is the widest this company has ever printed on a full-year basis. Across 5 fiscal years the operating margin has ranged 7.8% to 12.4%. The current quarter is running below every full year in that window.

The latest quarter's operating margin is 7.5%, −1.4 pp against the same quarter a year ago. Across 5 fiscal years the operating margin has ranged 7.8%–12.4%, and FY26's 12.4% is the top of that band — a record year.

🚨 Why the margin moved: operating margin went −1.4 pp year on year while gross margin went +1.1 pp — the loss came mostly from the gross line: input costs and pricing.

Worth repeating from the valuation section: cheap against its own history on record margins is not the same thing as cheap — a record margin flatters every ratio built on top of it.

FY26: 12.4% Operating margin by fiscal year, %, line (left); year-on-year change in the margin, in percentage points, line (right). 5-year window.
the widest a 7.8–12.4% band over 5 years
operating marginYoY change (pp)
13%2.0%11%1.3%10%0.5%8.8%−0.3%7.4%−1.0%%%12.4%1.8%FY22FY24FY26
13%2.0%11%1.3%10%0.5%8.8%−0.3%7.4%−1.0%%%12.4%1.8%FY22FY24FY26
Mar 26: 7.5% operating margin (−1.4 pp YoY) Quarterly operating margin, %, line (left); year-on-year change in the margin, in percentage points, line (right). Last 12 quarters. Operating profit as a share of revenue, per quarter.
Operating marginYoY change (pp)
15%4.8%12%3.1%9.8%1.5%7.2%−0.2%4.6%−1.9%%%7.5%−1.4%Jun 23Sep 24Mar 26
15%4.8%12%3.1%9.8%1.5%7.2%−0.2%4.6%−1.9%%%7.5%−1.4%Jun 23Sep 24Mar 26
07 · Net profit

Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.

Dynatrace, Inc. earned $0.0 B of net profit in the Mar 26 quarter, −50.0% year on year. Full-year FY26 profit was $0.2 B. The 4-year compound rate is 33.7%. That is 3.8% of the quarter's revenue. The same quarter a year earlier earned $0.0 B.

Mar 26 profit was $0.0 B, −50.0% year on year. On the full year, FY26 printed $0.2 B (−66.7%), and the 4-year compound rate is 33.7%.

FY26 profit $0.2 B (−66.7% YoY) Net profit bars, $ B (left); YoY growth-% line (right). 5-year window. A bar is red when it is lower than the year before.
33.7% a year over 4 years
Net profitYoY growth
0.5243%0.4160%0.377%0.1−6.5%0.0−90%$ B%$0B−66.7%FY22FY24FY26
0.5243%0.4160%0.377%0.1−6.5%0.0−90%$ B%$0B−66.7%FY22FY24FY26
Mar 26: $0.0 B (−50.0% YoY) Quarterly net profit bars, $ B (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
Net profit (quarterly)YoY growth
0.4871%0.3613%0.2356%0.198%0.0−160%$ B%$0B−50%Jun 23Sep 24Mar 26
0.4871%0.3613%0.2356%0.198%0.0−160%$ B%$0B−50%Jun 23Sep 24Mar 26

🚨 Why profit moved: revenue contributed +17.8% and the margin −1.4 pp — the quarter was revenue-led, with the margin roughly flat.

Pace comparison, last four quarters: profit −16.0% vs revenue +18.2%. Profit is growing slower than sales — costs are eating the growth before it reaches the bottom line.

08 · Cash flow — the router

Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.

Over the last 3 fiscal years 177% of Dynatrace, Inc.'s reported profit arrived as operating cash — the cash follows the profit. In FY26 that was $0.6 B of operating cash against $0.2 B of profit. After $0.0 B of capital spending, $0.5 B was left as free cash.

FY26: operating cash of $0.6 B against reported profit of $0.2 B, leaving free cash of $0.5 B after $0.0 B of capital spending. Across the last 3 fiscal years the conversion rate is 177% of profit.

Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.

FY26: CFO $0.6 B vs profit $0.2 B Operating cash flow and net profit by fiscal year, $ B; the line is free cash flow (CFO minus capital spending). 5-year window, annual resolution.
177% of 3-year profit arrived as cash
Operating cashNet profitFree cash
0.60.50.30.20.0$ B$1B$0B$1BFY22FY24FY26
0.60.50.30.20.0$ B$1B$0B$1BFY22FY24FY26
Mar 26: operating cash $0.2 B = 1,150% of the quarter's profit Operating cash per quarter, $ B (bars); conversion = operating cash as % of net profit (line, right). Last 12 quarters. Dashed line = 100%.
Operating cash (quarterly)Conversion100%
0.291,241%0.22911%0.15581%0.07250%0.00−80%$ B%$0B1,150%Jun 23Sep 24Mar 26
0.291,241%0.22911%0.15581%0.07250%0.00−80%$ B%$0B1,150%Jun 23Sep 24Mar 26

Why: conversion is measured cleanly, but the working-capital day-counts behind it sit below what we hold — the move is shown without inventing its driver.

Router verdict: the visible cash user is investment — the next section checks what the spending is buying.

09 · Where the cash goes

Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).

Dynatrace, Inc. does not report the debtor, inventory and payable day-counts a cash cycle is built from, so this section reads the investment side instead. Capital spending ran $0.0 B over the last 3 years. Averaged over those years that is 0.0% of FY26 revenue a year.

Working-capital day-counts are not in our numbers for this stock, so this section reads the investment side — where the cash is being put to work.

On the investment side: capital spending of $0.0 B over the last 3 fiscal years.

FY26: capex $0.0 B Capital spending per fiscal year, $ B (bars).
steady investment
Capex
0.0320.0240.0160.0080.000$ B$0BFY22FY24FY26
0.0320.0240.0160.0080.000$ B$0BFY22FY24FY26
Mar 26: capex $0.0 B in the quarter Capital spending per quarter, $ B (bars, left); free cash flow, $ B (line, right). Last 12 quarters.
Capex (quarterly)Free cash
0.0110.280.0080.210.0050.140.0030.070.0000.00$ B$ B$0B$0BJun 23Sep 24Mar 26
0.0110.280.0080.210.0050.140.0030.070.0000.00$ B$ B$0B$0BJun 23Sep 24Mar 26

The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.

10 · Return on equity

Return on equity Return on equity (ROE) is the profit the business earns on its shareholders’ money. With the full capital-employed split not in our numbers, ROE is the cleanest long ladder we can draw here.

Dynatrace, Inc. earns a ROE of 6% in FY26. That is up from a trough of 4% in FY22. Return on invested capital clears the cost of that capital by +0.7 percentage points, so growth here adds value rather than only size. The wiring behind it is 7.9% net margin on 0.46× asset turns.

FY26 ROE is 6%, recovered from a FY22 trough of 4% — the full ladder below shows the fall and the climb, undoctored.

Why the return is what it is — the wiring (FY26): 7.9% net margin × 0.46× asset turns × 1.69× balance-sheet leverage ≈ 6.1% on equity. Margin does its share; leverage is a meaningful part of the equation.

The capstone test — ROIC − WACC: 8.9% − 8.2% = a +0.7 pp spread. The 8.2% is an estimate of this company's own cost of capital — read the sign and the size of the spread, not the decimals. Positive but thin — value creation with little room for error.

FY26: ROE 6% Return on equity by fiscal year, % (line); ROIC by fiscal year, % (line). 5-year window, dips included. Dashed line = the 8.2% cost of capital used on this page.
the climb back from FY22's 4%
ROEROIC (annual)WACC
29%22%16%8.8%1.9%%6.1%8.4%FY22FY24FY26
29%22%16%8.8%1.9%%6.1%8.4%FY22FY24FY26
Mar 26: ROIC 8.7% (TTM) vs WACC 8.2% Trailing-twelve-month ROIC and ROE, per quarter, %; dashed line = the cost of capital. Last 12 quarters, put on a trailing-twelve-month basis and anchored to the annual figure.
ROIC (TTM)ROE (TTM)WACC
30%24%18%11%4.7%%8.7%6.5%Jun 23Sep 24Mar 26
30%24%18%11%4.7%%8.7%6.5%Jun 23Sep 24Mar 26
11 · Dividend

Dividend

Dynatrace, Inc. pays no dividend. Across the last 12 reported quarters it has declared no dividend per share, so there is no payout history to chart and no yield to quote. Companies at this stage typically reinvest earnings rather than distribute them, which makes the cash-flow and reinvestment sections the place that cash shows up.

Dynatrace, Inc. does not currently pay a dividend. Across the last 12 reported quarters the company has declared no dividend per share, so there is no payout history to chart and no yield to quote. Companies at this stage typically reinvest earnings instead of distributing them.

12 · Debt

Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.

Dynatrace, Inc. carries total debt of $0.2 B against shareholder equity of $2.6 B as of Mar 26, a debt-to-equity of 0.06 — effectively unlevered. On the annual view that ratio went from 0.26 in FY22 to 0.06 in FY26. The returns elsewhere on this page are therefore earned rather than borrowed.

Mar 26: total debt of $0.2 B against shareholder equity of $2.6 B — a debt-to-equity of 0.06. On the annual view, debt-to-equity went from 0.26 (FY22) to 0.06 (FY26). The returns on this page are earned, not borrowed.

FY26: debt $0.2 B at 0.06× equity Total debt by fiscal year, $ B (bars); debt-to-equity, × (line). 5-year window.
Total debtDebt-to-equity
0.40.28×0.30.21×0.20.14×0.10.08×0.00.01×$ B×$0B0.06×FY22FY24FY26
0.40.28×0.30.21×0.20.14×0.10.08×0.00.01×$ B×$0B0.06×FY22FY24FY26
Mar 26: debt $0.2 B, debt-to-equity 0.06 Total debt per quarter, $ B (bars); debt-to-equity, × (line). Last 12 quarters.
Total debt (quarterly)Debt-to-equity
0.170.062×0.130.054×0.090.045×0.040.036×0.000.028×$ B×$0B0.06×Jun 23Sep 24Mar 26
0.170.062×0.130.054×0.090.045×0.040.036×0.000.028×$ B×$0B0.06×Jun 23Sep 24Mar 26
13 · Ownership

Ownership There is no quarter-by-quarter holder register to read here, so we read the crowd through short interest — the slice of tradable shares currently sold short, positioned for a fall.

4.2% of Dynatrace, Inc.'s tradable float is currently sold short — some money is positioned against it. At typical trading volumes those positions would take about 1.6 days to buy back. There is no quarter-by-quarter holder register to read for this filer, so the crowd is read through short interest instead.

The latest reading: 4.2% of the float is sold short, and at typical trading volumes it would take about 1.6 days to buy those positions back. Some money is positioned against it. This is a single point-in-time reading — we do not yet hold its history, so we show no trend chart.

Short interest
4.2%
of the tradable float
Days to cover
1.6
at typical volumes

Why it sits there: who is doing the shorting, and why, does not travel with the number — the level is shown without inventing its story.

14 · Safety line

Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.

Dynatrace, Inc.: the Z-score reads 5.72. A Z-score above roughly 3 reads as safe and below roughly 1.8 as the distress zone, so this sits well clear of distress. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure.

Why it matters: a Z-score of 5.72 sits well clear of the distress zone — the balance sheet is not the risk here.

The safety line in one sentence: the Z-score reads 5.72.

15 · Related companies · Software - Application
CompanyScorePrice stageGrowth & earnings/35Capital efficiency/25Valuation/20Relative strength/20
1Salesforce, Inc.CRM 65.9/100Favorable setup85% evidence BREAKING OUT 18.4/35 Revenue 11.2% · PAT 45% · OPM change -1.4 pp 95% evidence 14.5/25 ROCE 11.4% · OPM 21.4% 76% evidence 15.7/20 P/E 15.6× · PEG 0.26 65% evidence 17.3/20 RS sector 12.1% · RS bench 11.1% · 1Y 1.4%6 of 12 weeks ahead 100% evidence
Exact sum: 18.4 + 14.5 + 15.7 + 17.3 = 65.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
2Manhattan Associates, Inc.MANH 65.1/100Thin evidence · provisional56% evidence BREAKING OUT 17.7/35 Revenue — · PAT — · OPM change -1 pp 39% evidence 20.1/25 ROCE 23.6% · OPM 23% 76% evidence 9.2/20 P/E 39.9× · PEG — 15% evidence 18.1/20 RS sector 20.2% · RS bench 19.7% · 1Y -2.6%10 of 12 weeks ahead 100% evidence
Exact sum: 17.7 + 20.1 + 9.2 + 18.1 = 65.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
3Atlassian CorporationTEAM 64.6/100Mixed-positive evidence61% evidence BREAKING OUT 25.1/35 Revenue 26% · PAT — · OPM change 14 pp 62% evidence 9.5/25 ROCE 7.8% · OPM 11.9% 76% evidence 10.0/20 P/E — · PEG — 0% evidence 20.0/20 RS sector 52.2% · RS bench 48.1% · 1Y 12.6%12 of 12 weeks ahead 100% evidence
Exact sum: 25.1 + 9.5 + 10 + 20 = 64.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
4Fair Isaac CorporationFICO 62.0/100Mixed-positive evidence81% evidence ASLEEP 27.5/35 Revenue 24.1% · PAT 28.4% · OPM change 4.9 pp 83% evidence 21.4/25 ROCE 30.4% · OPM 53.8% 76% evidence 12.3/20 P/E 34.5× · PEG 0.97 65% evidence 0.8/20 RS sector -31.1% · RS bench -31.9% · 1Y -32.9%3 of 12 weeks ahead 100% evidence
Exact sum: 27.5 + 21.4 + 12.3 + 0.8 = 62 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -31.1% and the one-year return is -32.9%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth.
5Autodesk, Inc.ADSK 59.8/100Mixed-positive evidence81% evidence TURNING 28.1/35 Revenue 18.3% · PAT 44.6% · OPM change 13.7 pp 83% evidence 15.1/25 ROCE 8.8% · OPM 28% 76% evidence 13.5/20 P/E 34.5× · PEG 0.74 65% evidence 3.1/20 RS sector -19.1% · RS bench -19.5% · 1Y -31.7%2 of 12 weeks ahead 100% evidence
Exact sum: 28.1 + 15.1 + 13.5 + 3.1 = 59.8 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -19.1% and the one-year return is -31.7%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth.
6Workday, Inc.WDAY 55.8/100Mixed-positive evidence81% evidence BREAKING OUT 25.3/35 Revenue 13.3% · PAT 73.9% · OPM change 11.6 pp 83% evidence 8.8/25 ROCE 3.1% · OPM 13.3% 76% evidence 7.0/20 P/E 38.3× · PEG 2.14 65% evidence 14.7/20 RS sector 3% · RS bench 0.7% · 1Y -19.6%11 of 12 weeks ahead 100% evidence
Exact sum: 25.3 + 8.8 + 7 + 14.7 = 55.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
7SAP SESAP 55.8/100Mixed-positive evidence81% evidence BREAKING OUT 14.6/35 Revenue 6.4% · PAT 20.2% · OPM change -0.9 pp 83% evidence 18.6/25 ROCE 19.7% · OPM 27.6% 76% evidence 12.4/20 P/E 20.1× · PEG 1 65% evidence 10.2/20 RS sector -3.3% · RS bench -4.4% · 1Y -20.1%7 of 12 weeks ahead 100% evidence
Exact sum: 14.6 + 18.6 + 12.4 + 10.2 = 55.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
8Intuit Inc.INTU 55.3/100Mixed-positive evidence81% evidence BREAKING OUT 19.6/35 Revenue 15% · PAT 32.2% · OPM change -1 pp 83% evidence 17.1/25 ROCE 14.9% · OPM 47% 76% evidence 14.1/20 P/E 23.5× · PEG 0.69 65% evidence 4.5/20 RS sector -34.4% · RS bench -36.3% · 1Y -53.8%5 of 12 weeks ahead 100% evidence
Exact sum: 19.6 + 17.1 + 14.1 + 4.5 = 55.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
9DocuSign, Inc.DOCU 54.6/100Mixed-positive evidence71% evidence BREAKING OUT 16.6/35 Revenue 8.4% · PAT -71.5% · OPM change 5.5 pp 83% evidence 10.4/25 ROCE 5.2% · OPM 13.4% 76% evidence 9.8/20 P/E 29.9× · PEG — 15% evidence 17.8/20 RS sector 16.5% · RS bench 15.1% · 1Y -16.8%10 of 12 weeks ahead 100% evidence
Exact sum: 16.6 + 10.4 + 9.8 + 17.8 = 54.6 · Decision use: Price leads the evidence: RS versus the benchmark is 15.1%, but earnings trajectory is weak. Wait for revenue and profit confirmation.
10Zoom Communications, Inc.ZM 53.6/100Mixed-positive evidence81% evidence TURNING 20.8/35 Revenue 5% · PAT 97.5% · OPM change 4.5 pp 83% evidence 11.9/25 ROCE 3.2% · OPM 25.1% 76% evidence 15.8/20 P/E 14.3× · PEG 0.55 65% evidence 5.1/20 RS sector -5.3% · RS bench -3.5% · 1Y 9.2%1 of 12 weeks ahead 100% evidence
Exact sum: 20.8 + 11.9 + 15.8 + 5.1 = 53.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
11Snowflake Inc.SNOW 53.4/100Mixed-positive evidence61% evidence LEADER 23.9/35 Revenue 31.1% · PAT — · OPM change 19.5 pp 62% evidence 4.0/25 ROCE -6.6% · OPM -23.4% 76% evidence 10.0/20 P/E — · PEG — 0% evidence 15.5/20 RS sector 36.7% · RS bench 36.8% · 1Y 43.6%12 of 12 weeks ahead 100% evidence
Exact sum: 23.9 + 4 + 10 + 15.5 = 53.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
12Datadog, Inc.DDOG 53.0/100Mixed-positive evidence71% evidence TURNING 25.0/35 Revenue 31.5% · PAT 42.1% · OPM change 4.8 pp 83% evidence 6.0/25 ROCE 0.1% · OPM 0.5% 76% evidence 8.5/20 P/E 520.7× · PEG — 15% evidence 13.5/20 RS sector 21.5% · RS bench 24.5% · 1Y 66.3%7 of 12 weeks ahead 100% evidence
Exact sum: 25 + 6 + 8.5 + 13.5 = 53 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
13Adobe Inc.ADBE 52.4/100Mixed-positive evidence81% evidence BREAKING OUT 16.1/35 Revenue 11.5% · PAT 5.2% · OPM change -2.1 pp 83% evidence 17.0/25 ROCE 12.1% · OPM 33.8% 76% evidence 12.2/20 P/E 14.8× · PEG 1.25 65% evidence 7.1/20 RS sector -15.6% · RS bench -16.4% · 1Y -31.5%4 of 12 weeks ahead 100% evidence
Exact sum: 16.1 + 17 + 12.2 + 7.1 = 52.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
14Paychex, Inc.PAYX 51.5/100Mixed-positive evidence81% evidence BREAKING OUT 20.8/35 Revenue 16.9% · PAT 6.3% · OPM change 7.5 pp 83% evidence 14.6/25 ROCE 6.4% · OPM 37.7% 76% evidence 6.2/20 P/E 19.8× · PEG 2.83 65% evidence 9.9/20 RS sector 1.6% · RS bench 1.7% · 1Y -10.2%11 of 12 weeks ahead 100% evidence
Exact sum: 20.8 + 14.6 + 6.2 + 9.9 = 51.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
15PTC Inc.PTC 49.9/100Mixed-negative evidence81% evidence TURNING 19.4/35 Revenue 19.5% · PAT 100% · OPM change -4.9 pp 83% evidence 12.6/25 ROCE 3.1% · OPM 27.7% 76% evidence 14.8/20 P/E 11× · PEG 0.81 65% evidence 3.1/20 RS sector -20.8% · RS bench -21.3% · 1Y -36.3%3 of 12 weeks ahead 100% evidence
Exact sum: 19.4 + 12.6 + 14.8 + 3.1 = 49.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
16Automatic Data Processing, Inc.ADP 49.2/100Mixed-negative evidence81% evidence BREAKING OUT 12.9/35 Revenue 6.7% · PAT 8.2% · OPM change -0.5 pp 83% evidence 15.1/25 ROCE 10% · OPM 23% 76% evidence 8.0/20 P/E 20.5× · PEG 2.13 65% evidence 13.2/20 RS sector 4.4% · RS bench 4.5% · 1Y -6.4%12 of 12 weeks ahead 100% evidence
Exact sum: 12.9 + 15.1 + 8 + 13.2 = 49.2 · Decision use: Price leads the evidence: RS versus the benchmark is 4.5%, but earnings trajectory is weak. Wait for revenue and profit confirmation.
17Dynatrace, Inc.this pageDT 49.1/100Thin evidence · provisional56% evidence LEADER 14.7/35 Revenue 18.9% · PAT -66.5% · OPM change -2.6 pp 53% evidence 9.6/25 ROCE 1.3% · OPM 7% 57% evidence 8.9/20 P/E 68.5× · PEG — 15% evidence 15.9/20 RS sector 19.6% · RS bench 19.9% · 1Y 14.1%12 of 12 weeks ahead 100% evidence
Exact sum: 14.7 + 9.6 + 8.9 + 15.9 = 49.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
18SS&C Technologies Holdings, Inc.SSNC 48.8/100Thin evidence · provisional56% evidence BREAKING OUT 18.6/35 Revenue — · PAT — · OPM change 0.6 pp 39% evidence 11.8/25 ROCE 2.8% · OPM 24.2% 76% evidence 10.5/20 P/E 17.8× · PEG — 15% evidence 7.9/20 RS sector -2.4% · RS bench -2.4% · 1Y -9.1%9 of 12 weeks ahead 100% evidence
Exact sum: 18.6 + 11.8 + 10.5 + 7.9 = 48.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
19Roper Technologies, Inc.ROP 47.6/100Mixed-negative evidence81% evidence BREAKING OUT 19.3/35 Revenue 10.9% · PAT 62.8% · OPM change -0.5 pp 83% evidence 11.7/25 ROCE 1.9% · OPM 27.7% 76% evidence 11.7/20 P/E 14× · PEG 1.43 65% evidence 4.9/20 RS sector -10.4% · RS bench -10.9% · 1Y -25.5%8 of 12 weeks ahead 100% evidence
Exact sum: 19.3 + 11.7 + 11.7 + 4.9 = 47.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
20Cadence Design Systems, Inc.CDNS 47.3/100Mixed-negative evidence81% evidence ASLEEP 24.5/35 Revenue 14.7% · PAT 36.2% · OPM change 9.4 pp 83% evidence 13.7/25 ROCE 4.9% · OPM 28.4% 76% evidence 7.0/20 P/E 74.6× · PEG 2.08 65% evidence 2.1/20 RS sector -20.6% · RS bench -19.4% · 1Y -25%2 of 12 weeks ahead 100% evidence
Exact sum: 24.5 + 13.7 + 7 + 2.1 = 47.3 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -20.6% and the one-year return is -25%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth.
21Shopify Inc.SHOP 45.8/100Mixed-negative evidence81% evidence BREAKING OUT 21.8/35 Revenue 32.5% · PAT -17.8% · OPM change 3.4 pp 83% evidence 15.3/25 ROCE 18.2% · OPM 17.6% 76% evidence 3.9/20 P/E 77× · PEG 4.14 65% evidence 4.8/20 RS sector -9.7% · RS bench -10.3% · 1Y -15.2%7 of 12 weeks ahead 100% evidence
Exact sum: 21.8 + 15.3 + 3.9 + 4.8 = 45.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
22Tyler Technologies, Inc.TYL 45.1/100Thin evidence · provisional56% evidence BREAKING OUT 17.1/35 Revenue — · PAT — · OPM change 0.5 pp 39% evidence 10.7/25 ROCE 2.3% · OPM 16.3% 76% evidence 9.3/20 P/E 38.8× · PEG — 15% evidence 8.0/20 RS sector -13.9% · RS bench -15.1% · 1Y -35.2%5 of 12 weeks ahead 100% evidence
Exact sum: 17.1 + 10.7 + 9.3 + 8 = 45.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
23ServiceNow, Inc.NOW 40.0/100Mixed-negative evidence81% evidence BREAKING OUT 13.0/35 Revenue 22.2% · PAT 0.5% · OPM change -7 pp 83% evidence 8.2/25 ROCE 1% · OPM 4.1% 76% evidence 4.0/20 P/E 62× · PEG 4.61 65% evidence 14.8/20 RS sector 3.1% · RS bench 0.9% · 1Y -27.3%10 of 12 weeks ahead 100% evidence
Exact sum: 13 + 8.2 + 4 + 14.8 = 40 · Decision use: Price leads the evidence: RS versus the benchmark is 0.9%, but earnings trajectory is weak. Wait for revenue and profit confirmation.
24Uber Technologies, Inc.UBER 39.6/100Mixed-negative evidence71% evidence ASLEEP 15.8/35 Revenue 16.7% · PAT -23.2% · OPM change 1.8 pp 83% evidence 9.8/25 ROCE 4% · OPM 13.3% 76% evidence 10.6/20 P/E 15.9× · PEG — 15% evidence 3.4/20 RS sector -16.1% · RS bench -16.1% · 1Y -28%2 of 12 weeks ahead 100% evidence
Exact sum: 15.8 + 9.8 + 10.6 + 3.4 = 39.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
25Fiserv, Inc.FISV 38.9/100Mixed-negative evidence81% evidence TURNING 8.0/35 Revenue -1.2% · PAT -33% · OPM change -11.5 pp 83% evidence 10.7/25 ROCE 1.8% · OPM 19.2% 76% evidence 16.0/20 P/E 9.4× · PEG 0.6 65% evidence 4.2/20 RS sector -28% · RS bench -29.4% · 1Y -62.5%0 of 12 weeks ahead 100% evidence
Exact sum: 8 + 10.7 + 16 + 4.2 = 38.9 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity.
26Strategy IncMSTR 26.7/100Adverse evidence67% evidence TURNING 4.8/35 Revenue 7.8% · PAT -734.6% · OPM change -19064.4 pp 83% evidence 5.2/25 ROCE -14.3% · OPM — 61% evidence 10.8/20 P/E 15× · PEG — 15% evidence 5.9/20 RS sector -25.3% · RS bench -27.3% · 1Y -63.4%2 of 12 weeks ahead 100% evidence
Exact sum: 4.8 + 5.2 + 10.8 + 5.9 = 26.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
27Bending Spoons S.p.A.BSP 49.6/100Thin evidence · provisional18% evidence 17.7/35 Revenue — · PAT — · OPM change 13.5 pp 10% evidence 11.9/25 ROCE 5.5% · OPM 38.8% 57% evidence 10.0/20 P/E — · PEG — 0% evidence 10.0/20 RS sector — · RS bench — · 1Y — 0% evidence
Exact sum: 17.7 + 11.9 + 10 + 10 = 49.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
28Unity Software Inc.U 46.0/100Thin evidence · provisional48% evidence BREAKING OUT 12.0/35 Revenue 7.5% · PAT — · OPM change -39.7 pp 40% evidence 6.2/25 ROCE -6.5% · OPM -69.1% 57% evidence 10.0/20 P/E — · PEG — 0% evidence 17.8/20 RS sector 20.5% · RS bench 18.6% · 1Y -8.5%12 of 12 weeks ahead 100% evidence
Exact sum: 12 + 6.2 + 10 + 17.8 = 46 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
29Quantinuum Inc.QNT 43.7/100Thin evidence · provisional15% evidence ASLEEP 16.4/35 Revenue — · PAT — · OPM change -1316.6 pp 10% evidence 7.3/25 ROCE -9% · OPM — 46% evidence 10.0/20 P/E — · PEG — 0% evidence 10.0/20 RS sector — · RS bench — · 1Y —0 of 3 weeks ahead 0% evidence
Exact sum: 16.4 + 7.3 + 10 + 10 = 43.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
30Figma, Inc.FIG 34.9/100Thin evidence · provisional42% evidence BREAKING OUT 14.7/35 Revenue 41.4% · PAT — · OPM change -58.6 pp 40% evidence 6.0/25 ROCE -9.3% · OPM -41.2% 57% evidence 10.0/20 P/E — · PEG — 0% evidence 4.2/20 RS sector -25.2% · RS bench -28.1% · 1Y -59.4%11 of 12 weeks ahead 70% evidence
Exact sum: 14.7 + 6 + 10 + 4.2 = 34.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.

Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led S&P 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.

16 · Frequently asked questions

Frequently asked questions

What is Dynatrace, Inc.'s stock price today?

Dynatrace, Inc. trades at $55.2, +14.1% over the past year. The company is valued at $16.0 B. The stock sits at the very top of its 52-week range ($32–$55), +32.0% versus its 200-day average. On the tape, the price is topping out, 13 weeks in. — as of 17 September 2026.

What were Dynatrace, Inc.'s latest quarterly results?

Dynatrace, Inc. reported revenue of $0.5 B and net profit of $0.0 B for the Mar 26 quarter. Revenue rose 17.8% and profit fell 50.0% year on year. Earnings per share were $0.06. The operating margin was 7.5%, 1.4 pp lower than a year earlier. — as of 17 September 2026.

What is Dynatrace, Inc.'s revenue?

Dynatrace, Inc. reported revenue of $0.5 B in the Mar 26 quarter, +17.8% year on year. For the full FY26 fiscal year, revenue was $2.0 B (+18.8%). Over the last 4 years revenue compounded at 21.4% a year. — as of 17 September 2026.

What is Dynatrace, Inc.'s profit?

Dynatrace, Inc. earned $0.0 B of net profit in the Mar 26 quarter, −50.0% year on year. Full-year FY26 profit was $0.2 B. The operating margin ran 7.5% in the latest quarter. — as of 17 September 2026.

What is Dynatrace, Inc.'s market cap?

Dynatrace, Inc.'s market capitalisation is $16.0 B at a stock price of $55.2. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 17 September 2026.

What is Dynatrace, Inc.'s P/E ratio?

Dynatrace, Inc. trades at a P/E of 110.4×, at the 72nd percentile of its own 5-year range, against a long-run median of 90.0×. This is a comparison with the stock's own history, not a value call — as of 17 September 2026.

Does Dynatrace, Inc. pay a dividend?

No — Dynatrace, Inc. has declared no dividend per share in any of its last 12 reported quarters, so there is no payout history and no yield to quote. That is a reading of the filed statements, not an estimate. — as of 17 September 2026.

Is Dynatrace, Inc. overvalued?

On its own history, Dynatrace, Inc. looks expensive: its P/E of 110.4× sits at the 72nd percentile of its 5-year range (long-run median 90.0×). That is a percentile read against the stock's own past, not a price opinion or a direction call. One caveat: margins are the best this company has ever printed — cheap on record margins is not the same thing as cheap. — as of 17 September 2026.

Is Dynatrace, Inc. growing?

Not right now — Dynatrace, Inc.'s latest numbers are shrinking: latest-quarter revenue +17.8% year on year, profit −50.0%, and the margin −1.4 pp at 7.5%. The 4-year compound rates are 21.4% (revenue) and 33.7% (profit). The earnings engine currently reads: deteriorating — as of 17 September 2026.

How is Dynatrace, Inc. performing?

Dynatrace, Inc. is topping out, 13 weeks in. Its latest quarter's revenue rose 17.8% and profit fell 50.0% year on year. Against the S&P 500 it has been ahead on a trailing-13-week view for 13 weeks. This describes what the data did, not a rating. — as of 17 September 2026.

What stage is Dynatrace, Inc. in?

Deteriorating — profit and EPS growth are shrinking (profit growth −64.6% latest against +800.0% at its 12-quarter best), ROCE holding at 8.6%. The read comes from the last 12 quarters of growth (revenue growth +18.1% latest, profit growth −64.6% latest, eps growth −66.3% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 17 September 2026.

Is Dynatrace, Inc. in an uptrend?

It is stalling — the price is topping out (week 13 of stage 3), trading +32.0% versus its 200-day average and at the very top of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 17 September 2026.

Is Dynatrace, Inc. beating the market?

On recent form, yes — Dynatrace, Inc. has been ahead of the S&P 500 on a trailing-13-week view for 13 straight weeks, the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 7.1 years the stock moved +112% against the S&P 500's +158% — behind the index over the full window. — as of 17 September 2026.

Will Dynatrace, Inc.'s stock price go up?

This page publishes no price forecast for Dynatrace, Inc. What it measures instead: the stock price is $55.2, the price is topping out 13 weeks in. Its P/E of 110.4× sits at the 72nd percentile of its own 5-year range. Direction is not something this site claims to know. — as of 17 September 2026.

Is the market betting against Dynatrace, Inc.?

Somewhat — short interest is 4.2% of Dynatrace, Inc.'s tradable float, about 1.6 days to cover at typical volumes. A moderate reading: some money is positioned against it. With no quarter-by-quarter holder register here, short interest is the cleanest crowd read we hold — as of 17 September 2026.

Does Dynatrace, Inc. have too much debt?

No — Dynatrace, Inc.'s debt-to-equity is 0.06. A year-by-year borrowings ladder is not in our numbers for this stock, so the latest reading is the cleanest hold. The returns on this page are earned, not borrowed — as of 17 September 2026.

What is Dynatrace, Inc.'s capex?

Dynatrace, Inc. spent $0.0 B on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was $0.0 B. — as of 17 September 2026.

What is Dynatrace, Inc.'s cash flow?

Dynatrace, Inc. generated $0.6 B of operating cash flow in FY26 and $0.5 B of free cash flow after $0.0 B of capital spending. Reported profit that year was $0.2 B, so operating cash ran ahead of profit. — as of 17 September 2026.

Is Dynatrace, Inc.'s profit real cash?

Yes — over the last 3 fiscal years, 177% of Dynatrace, Inc.'s reported profit arrived as operating cash. In FY26, operating cash was $0.6 B against reported profit of $0.2 B. The cash then goes mostly into building capacity. Cash-flow resolution is annual — as of 17 September 2026.

How financially safe is Dynatrace, Inc.?

On the balance sheet, the Z-score reads 5.72 — above roughly 3 is safe, below roughly 1.8 is the distress zone. That sits well clear of trouble. — as of 17 September 2026.

Where is Dynatrace, Inc. in its business cycle?

Dynatrace, Inc.'s FY26 operating margin was 12.4%, against a 5-year band of 7.8%–12.4%: the top of the band — a record year. Record profitability is late-cycle territory: every ratio flatters at the top, and the story leans on margins holding. The latest quarter ran 7.5%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 17 September 2026.

What could break the Dynatrace, Inc. story?

The sharpest disagreement: the price moved +14.1% in a year while annual EPS moved −66.0% — the difference is re-rating, and re-rating has to be repaid with earnings. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 17 September 2026.

Is Dynatrace, Inc. a stock worth studying right now?

This is not investment advice. The machine read: Dynatrace, Inc.'s price has outrun its earnings. +14.1% in a year against EPS −66.0% — the market is paying now for delivery later. The sharpest open question: whether earnings grow into a price that has already moved. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 17 September 2026.

Sector Alpha — machine-written from the numbers · Data as of 2026-09-17. Every chart on this page is drawn by deterministic code from the raw series — no forecasts, no price opinions, and nothing here is investment advice.

Not SEBI Registered !! Not Investment advice !!

Chat with this pageChat with pageChatChatGPTClaudePerplexityGoogle AI